Improved adherence to practice guidelines yields better outcome in high-risk patients with acute coronary syndrome without ST elevation: Findings from nationwide FINACS studies

Journal of Internal Medicine

Volumn 256, Issue 4, 2004, Pages 316-323

  Vikman, Saila ^a   Airaksinen, K E J ^b   Tierala, I ^c   Peuhkurinen, K ^d   Majamaa Voltti, K ^e   Niemela M ^e   Tuunanen, H ^b   Nieminen, M S ^c   Niemela K ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Acute coronary syndrome; Education; Guidelines; Implementation; Risk stratification

Indexed keywords

CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PRACTICE; CONTINUING EDUCATION; DRUG USE; FEMALE; FINLAND; HEALTH PROGRAM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OUTCOMES RESEARCH; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STROKE; SURVIVAL TIME; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; DIABETES MELLITUS; EDUCATION, MEDICAL, CONTINUING; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PATIENT COMPLIANCE; PRACTICE GUIDELINES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 4644319649     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01374.x     Document Type: Article

References (27)

1. Boersma E, Harrington RA, Moliterno DJ et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002: 359: 189-98.
2. Cannon CP, Weintraub WS, Demopolous LA et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Meet 2001; 344: 1879-87.
3. Wallentin L, Lagerqvist B, Husted S et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 2000; 356: 9-16.
4. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. Circulation 2000; 102: 1193-209.
5. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2002; 106: 1893-900.
6. Task Force Report. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Eur Heart J 2000; 21: 1406-32.
7. Fox KAA, Goodman SG, Anderson FA Jr et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1414-24.
8. Hasdai D, Behar S, Wallentin L et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23: 1190-201.
9. Steg PG, Goldberg RJ, Gore JM et al. Baseline characteristics, management, practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90: 358-63.
10. Vikman S, Niemelä K, Ilva T et al. Underuse of evidence-based treatment modalities in diabetic patients with non-ST elevation acute coronary syndrome. A prospective nation wide study on acute coronary syndrome (FINACS). Diabetes Research and Clinical Practice 2003; 61: 39-48.
11. Vikman S, Airaksinen KEJ, Peuhkurinen K et al. Gap between guidelines and management of patients with acute coronary syndrome without persistent ST elevation. Finnish prospective follow-up survey. Scand Cardiovasc J 2003; 37: 187-92.
12. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
13. Chowdhury TA, Lasker SS, Dyer PH. Comparison of secondary prevention measures after myocardial infarction in subjects with and without diabetes mellitus. J Intern Med 1999; 245: 565-70.
14. Axtell SS, Ludwig E, Lope-Candales P. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction. Clin Cardiol 2001; 24: 114-8.
15. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education. JAMA 1995; 274: 700-5.
16. Marciniak TA, Ellerbeck EF, Radford MJ et al. Improving the quality of care for Medicare patients with acute myocardial infarction in the US from 1990 through 1999. JAMA 1998; 279: 1351-7.
17. Soumerai SB, McLaughlin TJ, Gurwitz JH et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomised controlled trial. JAMA 1998; 279: 1358-63.
18. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a cardiac hospitalisation atherosclerosis management program (CHAMP). Am J Cardiol 2001; 87: 819-22.
19. Grimshaw JM, Russel IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-22.
20. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001; 284: 2578-85.
21. Cannon CP, Gibson CM, Lambrew CT et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941-7.
22. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med 2003; 348: 2218-27.
23. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994; 331: 1136-42.
24. Froehlich JB, Karavite D, Russman PL et al. American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery. J Vasc Surg 2002; 36: 758-63.
25. Roberts RR, Zalenski RJ, Mensah EK et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalisation in patients with chest pain: a randomised controlled trial. JAMA 1997; 278: 1670-6.
26. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do 'America's Best Hospitals' perform better for acute myocardial infarction? N Engl J Med 1999; 340: 286-92.
27. Giugliano RP, Lloyd-Jones DM, Camargo CAJ, Makary MA, O'Donnell CJ. Association of unstable angina guideline care with improved survival. Arch Intern Med 1999; 160: 1775-80.